- Home
- / Marvel Biosciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Marvel Biosciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.1
2024-10-29
Market Capitalization
$5.2 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CAD | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|
| Operating expense total | 100.0K | 2.6M | 1.7M | 2.1M | 1.3M | 1.5M | |
| EBITDA | (100.0K) | (2.6M) | (1.7M) | (2.1M) | (1.3M) | (1.5M) | |
| EBIT | (100.0K) | (2.5M) | (1.7M) | (2.0M) | (1.5M) | (1.9M) | |
| Interest income | 2.0K | 3.0K | 2.0K | ||||
| Interest expense | 2.0K | 2.0K | 39.0K | 114.0K | 268.0K | ||
| Pre tax profit | (98.0K) | (10.0K) | (3.0M) | (2.6M) | (2.3M) | (1.6M) | (2.2M) |
| Net Income | (98.0K) | (10.0K) | (3.0M) | (2.6M) | (2.3M) | (1.6M) | (2.2M) |